HK1119938A1 - Pharmaceutical composition containing chenopodium ambrosioides extract and its preparation process and application - Google Patents

Pharmaceutical composition containing chenopodium ambrosioides extract and its preparation process and application

Info

Publication number
HK1119938A1
HK1119938A1 HK08111964.1A HK08111964A HK1119938A1 HK 1119938 A1 HK1119938 A1 HK 1119938A1 HK 08111964 A HK08111964 A HK 08111964A HK 1119938 A1 HK1119938 A1 HK 1119938A1
Authority
HK
Hong Kong
Prior art keywords
chenopodium ambrosioides
application
pharmaceutical composition
composition containing
preparation process
Prior art date
Application number
HK08111964.1A
Other languages
English (en)
Inventor
Feng Wei
Zhengliang Ye
Jun Gao
Chongnian Luo
Dekun Li
Jianming Chen
Yonghong Zhu
Junfeng Xiong
Xiaoli Zheng
Guangming Zhang
Ying Zhao
Original Assignee
Tasly Pharmaceutical Group Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN2005101353590A external-priority patent/CN1990007B/zh
Priority claimed from CN2005101353586A external-priority patent/CN1990006B/zh
Priority claimed from CN2006101365003A external-priority patent/CN101172132B/zh
Application filed by Tasly Pharmaceutical Group Co filed Critical Tasly Pharmaceutical Group Co
Publication of HK1119938A1 publication Critical patent/HK1119938A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK08111964.1A 2005-12-31 2008-10-30 Pharmaceutical composition containing chenopodium ambrosioides extract and its preparation process and application HK1119938A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN2005101353590A CN1990007B (zh) 2005-12-31 2005-12-31 一种治疗胃病的组合物、制备方法及其用途
CN2005101353586A CN1990006B (zh) 2005-12-31 2005-12-31 一种土荆芥提取物、其制剂、制备方法与用途
CN2006101365003A CN101172132B (zh) 2006-10-30 2006-10-30 一种治疗胃病的自乳化制剂及其制备方法
PCT/CN2006/003691 WO2007076699A1 (fr) 2005-12-31 2006-12-29 Composition pharmaceutique contenant un extrait de chenopodium ambrosioides et son procédé de préparation et son application

Publications (1)

Publication Number Publication Date
HK1119938A1 true HK1119938A1 (en) 2009-03-20

Family

ID=38227910

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08111964.1A HK1119938A1 (en) 2005-12-31 2008-10-30 Pharmaceutical composition containing chenopodium ambrosioides extract and its preparation process and application

Country Status (7)

Country Link
US (2) US8361515B2 (fr)
EP (1) EP1982705B8 (fr)
JP (1) JP5844954B2 (fr)
KR (1) KR101164516B1 (fr)
HK (1) HK1119938A1 (fr)
MY (1) MY148473A (fr)
WO (1) WO2007076699A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101164516B1 (ko) 2005-12-31 2012-07-13 태슬리 파마슈티컬 그룹 컴퍼니 리미티드 양명아주 추출물을 함유하는 약학 조성물, 및 이의 제조방법 및 용도
US20100316738A1 (en) * 2009-06-12 2010-12-16 Desmond JIMENEZ Methods of inhibiting, preventing, killing and/or repelling insects using simulated blends of chenopodium extracts
JP2012077033A (ja) * 2010-10-01 2012-04-19 Kinki Univ ヘリコバクターピロリの運動能阻害剤
WO2012104569A1 (fr) 2011-02-02 2012-08-09 GILHOLM, Stephen, Philip Composition de monoterpenoïdes pour le traitement de cancer
US9107420B2 (en) 2014-01-13 2015-08-18 Eliana Ellern Animal shampoo
CN104474350A (zh) * 2014-12-20 2015-04-01 济南伟传信息技术有限公司 一种治疗胃溃疡的茶
WO2017149392A1 (fr) * 2016-03-04 2017-09-08 Sharon Anavi-Goffer Compositions auto-émulsifiantes de modulateurs du récepteur cb2
JP2021035912A (ja) 2017-12-20 2021-03-04 石原産業株式会社 有害生物防除用組成物及び有害生物の防除方法
CN110133140B (zh) * 2019-05-23 2022-07-12 吉林化工学院 一种白鲜地上部分挥发油成分鉴定及其抑菌活性研究

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039699A (en) * 1989-03-27 1991-08-13 Lederle (Japan), Ltd. Anti-peptic ulcer agent
US5696169A (en) * 1992-03-13 1997-12-09 Otsuka Pharmaceutical Co., Ltd. Antibacterial and antifungal activity method, therapeutic method of infectious diseases and preserving method of cosmetics
CN1052646C (zh) * 1995-03-23 2000-05-24 张涌川 一种治疗胃脘痛的胶丸及其制备方法
AU1881600A (en) * 1998-12-23 2000-07-31 Alza Corporation Dosage forms comprising porous particles
US20030091657A1 (en) * 2000-03-17 2003-05-15 Helene Chiasson Plant acaricidal compositions and method using same
TNSN03139A1 (fr) * 2001-06-21 2005-12-23 Pfizer Prod Inc Formulations auto-emulsionnables d'inhibiteurs de la proteine de transfert d'ester de cholesteryle
JP4081312B2 (ja) * 2002-06-28 2008-04-23 佐藤製薬株式会社 外用抗真菌剤
CN1506118A (zh) * 2002-12-06 2004-06-23 苏少宁 一种用于消化道检查窥视设备的消毒液
CN101172132B (zh) 2006-10-30 2011-10-05 天津天士力制药股份有限公司 一种治疗胃病的自乳化制剂及其制备方法
RU2423111C2 (ru) 2005-12-31 2011-07-10 Тяньцзинь Тасли Фармасьютикл Ко., Лтд. ЭКСТРАКТЫ ПРИМЕНЯЕМОГО В КИТАЙСКОЙ МЕДИЦИНЕ РАСТЕНИЯ Chenopodium ambrosioides L., КОМПОЗИЦИИ, ВКЛЮЧАЮЩИЕ УПОМЯНУТЫЕ ЭКСТРАКТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ
KR101164516B1 (ko) 2005-12-31 2012-07-13 태슬리 파마슈티컬 그룹 컴퍼니 리미티드 양명아주 추출물을 함유하는 약학 조성물, 및 이의 제조방법 및 용도
CN1990006B (zh) 2005-12-31 2011-10-05 天津天士力制药股份有限公司 一种土荆芥提取物、其制剂、制备方法与用途

Also Published As

Publication number Publication date
MY148473A (en) 2013-04-30
KR20090019760A (ko) 2009-02-25
JP5844954B2 (ja) 2016-01-20
KR101164516B1 (ko) 2012-07-13
EP1982705A1 (fr) 2008-10-22
US8586108B2 (en) 2013-11-19
EP1982705B8 (fr) 2012-08-22
US8361515B2 (en) 2013-01-29
JP2009522208A (ja) 2009-06-11
US20090130203A1 (en) 2009-05-21
US20130178516A1 (en) 2013-07-11
WO2007076699A1 (fr) 2007-07-12
EP1982705B1 (fr) 2012-07-18
EP1982705A8 (fr) 2008-12-10
EP1982705A4 (fr) 2009-07-29

Similar Documents

Publication Publication Date Title
HK1119938A1 (en) Pharmaceutical composition containing chenopodium ambrosioides extract and its preparation process and application
Fattahi et al. Total phenolic and flavonoid contents of aqueous extract of stinging nettle and in vitro antiproliferative effect on hela and BT-474 Cell lines
KR102078204B1 (ko) 관절 건강을 위한 조성물 및 방법
Ghareeb et al. In vitro screening for anti-acetylcholiesterase, anti-oxidant, anti-glucosidase, anti-inflammatory and anti-bacterial effect of three traditional medicinal plants
JP2018138598A (ja) 骨障害、軟骨障害又はその両方の管理又は改善用組成物及び方法
EA201590458A8 (ru) Способ получения экстракта, извлекаемого из сахарного тростника, и экстракт
Zendehbad et al. Flavonoids and phenolic content in wheat grass plant (Triticum aestivum)
Bodhankar et al. Formulation and in vitro evaluation of dental gel containing ethanglic extract of Mimosa pudica
Malm et al. Anti-Helicobacter pylori activity in vitro of chamomile flowers, coneflower herbs, peppermint leaves and thyme herbs–a preliminary report
DE50210906D1 (de) Arzneimittel enthaltend deuterium zur behandlung der zuckerkrankheit
Pavel et al. Phytochemical and pharmacological research on some extracts obtained from Serpylli herba
Surana et al. Phytochemical analysis and antidepressant activity of Ixora coccinea extracts in experimental models of depression in mice
Hamidpour et al. Chemistry, pharmacology and medicinal property of Russian olive (Elaeagnus angustifolia L.)
Bozorgi et al. Antioxidant activity of Lallemantia royleana (Benth.) seed extract
Mykhailenko et al. The comparative analysis of carboxylic acid composition of four Iris species from Ukraine
Chemsa et al. Antibiofilm formation, antioxidant and anticholinesterase activities of essential oil and methanol extract of Marrubium deserti de Noé
Victório et al. Vasodilator activity of extracts of field Alpinia purpurata (Vieill) K: Schum and A. zerumbet (Pers.) Burtt et Smith cultured in vitro
Antonio et al. Biological properties and antioxidant activity of hawthorn Crataegus mexicana
MD3972C2 (ro) Remediu şi metodă de tratament al stărilor precanceroase
Nguyen et al. In vitro antioxidant, anti-diabetic, anti-cholinesterase, tyrosinase and nitric oxide inhibitory potential of fruiting bodies of Coprinellus micaceus
EJIKE-ILIEMENE et al. Anti-diarrhoea property of crude aqueous leave extract of red apple Psidium guajava in castor oil-induced diarrhoea in rats
Calvo et al. Identification of polyphenols in sea fennel (Crithmum maritimum) and Seaside Arrowgrass (Triglochin maritima) extracts with antioxidant, ACE-I, DPP-IV and PEP-inhibitory capacity
NZ702155A (en) Novel pharmacological use of cimicifuga extract
Singh et al. Bioactivity guided fractionation of ethanol extract of Caesalpinia digyna Rottler roots
梅文莉 et al. Bioactive Constituents from Hydnocarpus hainanensis (Merr.) Sleum.